Istruzione e Formazione
Professor Clive Ballard Wins 2019 International Outstanding Achievement Award
In addition to drug development, Professor Ballard is also heavily involved in the study of prevention strategies and alternative treatment opportunities for AD. For example, along with colleagues, he developed PROTECT, an online-based project, now adopted by the Dementia Platform UK, that aims to understand why some people develop dementia by collecting participants' information on demographics, lifestyle, cognitive abilities, and DNA samples, year after year.
Professor Ballard has published over 500 peer-reviewed manuscripts, and has been cited over 50,000 times. In the past 15 years, he has garnered more than £100 million in research funding. Professor Ballard also held leadership positions in a number of organizations, including Director of Research for Alzheimer's Society in the UK (2003-2013), where he guided national policy around dementia treatment and care. In 2015, Professor Ballard was elected a Fellow of the Academy of Medical Sciences. Professor Ballard is currently the Pro-Vice Chancellor and Executive Dean,
Professor of Age Related Diseases at the University of Exeter College of Medicine and Health.
The Weston Brain Institute is Canada's largest privately funded national initiative aimed at accelerating breakthrough discoveries for the treatment of neurodegenerative diseases of aging, including Alzheimer's disease, Parkinson's disease, and frontotemporal dementia. The Institute directly supports Canada's world-class neuroscience research community and focuses on high-risk, high-reward projects, independent of commercial potential, that address the existing translational gap in neurodegenerative research using an innovative fast-track granting model. In Canada , the Institute is a program of The W. Garfield Weston Foundation, and in Europe , the Weston Brain Institute is a program of the Selfridges Group Foundation. www.westonbrain.org; twitter: @westonbrain; Facebook: WestonBrainInstitute
The Selfridges Group Foundation was set up to coordinate charitable and philanthropic activities within Selfridges Group. Selfridges Group consists of Brown Thomas and Arnotts in Ireland , Holt Renfrew in Canada , de Bijenkorf in the Netherlands , and Selfridges in the UK. As part of its philanthropic work, the Selfridges Group Foundation supports medical research into treatments for brain disorders in Ireland , the Netherlands and the United Kingdom .
The Selfridges Group Foundation has most recently awarded four grants through its Rapid Response programme in Ireland , the Netherlands , and the United Kingdom . The exceptional scientists working on these projects are pursuing novel, high-risk, high-reward translational research in neurodegenerative diseases of aging.
The four recent grantees are:
Annette Cremin
Annette.cremin@selfridges.co.uk
Georgia Frost
+44-(0)-7872-544-077
georgia.frost@selfridges.co.uk